Portfolio company
Valcare Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops transcatheter repair and replacement technologies for heart valves to treat patients with mitral and tricuspid regurgitation.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
TRiCares
This company develops a catheter-based tricuspid valve replacement system for patients suffering from tricuspid regurgitation.
CroiValve
The company develops a transcatheter heart valve system to treat tricuspid regurgitation in patients unsuitable for open-heart surgery.
CroíValve
The company develops a minimally invasive transcatheter valve system to treat tricuspid regurgitation for elderly and frail cardiac patients.
Coramaze
This medical technology company develops a transcatheter valve repair system for treating patients with tricuspid regurgitation and other structural heart conditions.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
HVR Cardio
This company develops transcatheter mitral valve repair devices to treat patients with mitral regurgitation.
Capstan Medical
This company develops robotic catheter platforms and implants to treat mitral and tricuspid valve disease for patients requiring heart valve repair or replacement.
Meacor
Meacor develops a catheter-based medical device for repairing heart valves to treat patients with mitral and tricuspid regurgitation without undergoing open-heart surgery.